Table 1.
Cohort | Consortium | Patients at baseline | Modalities | Longitudinal (yes/no) | Study type |
---|---|---|---|---|---|
A4 [16] | Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease | 6945 | 7 | Noa | Clinical trial |
ABVIB [17] | Aging Brain: Vasculature, Ischemia, and Behavior | 280 | 2 | Yes | Observational study |
ADNI [18] | The Alzheimer’s Disease Neuroimaging Initiative | 2249 | 12 | Yes | Observational study |
AIBL [19] | The Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing | 1378 | 9 | Yes | Observational study |
ANMerge [20] | AddNeuroMed | 1703 | 10 | Yes | Observational study |
ARWIBO [21] | Alzheimer’s Disease Repository Without Borders | 2617 | 10 | Yes | Observational study |
DOD-ADNI [22] | Effects of TBI & PTSD on Alzheimer’s Disease in Vietnam Vets | 458 | 11 | Yes | Observational study |
EDSD [23] | The European DTI Study on Dementia | 474 | 7 | No | Observational study |
EMIF-1000 [24] | European Medical Information Framework | 1199 | 10 | No | Meta-cohort |
EPAD V.IMI [25] | European Prevention of Alzheimer’s Dementia | 2096 | 9 | Yes | Observational study |
I-ADNI [26] |
The Italian Alzheimer’s Disease Neuroimaging Initiative |
262 | 5 | No | Observational study |
JADNI [27] | Japanese Alzheimer’s Disease Neuroimaging Initiative | 567 | 9 | Yes | Observational study |
NACC [28] | The National Alzheimer’s Coordinating Center | 40,948 | 11 | Yes | Memory clinic database |
OASIS-1 [29] and OASIS-2 [30] | Open Access Series of Imaging Studies | 564 | 3 | Yes | Observational study |
PREVENT-AD [31] | Pre-symptomatic Evaluation of Experimental or Novel Treatments for Alzheimer’s Disease | 348 | 8 | Yes | Clinical trial |
PharmaCog [32] | Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development | 147 | 6 | Yes | Observational study |
ROSMAP [33] | The Religious Orders Study and Memory and Aging Project | 3626 | 7 | Yes | Observational study |
VASCULAR [34] | The Vascular Contributors to Prodromal Alzheimer’s disease | 250 | 8 | No | Non-interventional cohort study |
VITA [35] | Vienna Transdanube Aging | 606 | 5 | Yes | Observational study |
WMH-AD [36] | White Matter Hyperintensities in Alzheimer’s Disease | 90 | 5 | No | Observational study |
A complete overview about the collected data modalities can be found under https://adata.scai.fraunhofer.de/modality
aFollow-up assessments were planned for A4 but no according data was released at the time of this publication